Disclosed is a use of a composition containing an iron (II) amino acid chelate used in the preparation of a drug for ameliorating diabetes, wherein the drug comprises an effective dose of a composition containing an iron (II) amino acid chelate for ameliorating diabetes and a pharmaceutically acceptable carrier thereof.